Parabolic Drugs has informed that a meeting of the Board of Directors of the company is scheduled to be held on May 28, 2016, to consider and approve/take on record the Audited Financial Results of the Company for the quarter ended March 31, 2016.
The above information is a part of company’s filings submitted to BSE.